Product Pathways - PI3K / Akt Signaling
PhosphoPlus® GSK-3β (Ser9) Antibody Duet #8213
|Duet Includes||Quantity||Applications||Reactivity||MW (kDa)||Isotype|
|Phospho-GSK-3β (Ser9) (D85E12) XP® Rabbit mAb #5558||100 µl||W IP IF-IC F||H M R Hm||46||Rabbit IgG|
|GSK-3β (3D10) Mouse mAb #9832||100 µl||W IP IF-IC F||H M R Hm Mk||46||Mouse IgG2a|
Reactivity Key: H=Human M=Mouse R=Rat Hm=Hamster Mk=Monkey
Species in parentheses are predicted to react based on 100% sequence homology.
PhosphoPlus® Duets from Cell Signaling Technology (CST) provide a means to assess protein activation status. Each Duet contains an activation-state and total protein antibody to your target of interest. These antibodies have been selected from CST's product offering based upon superior performance in specified applications.
Glycogen synthase kinase-3 (GSK-3) was initially identified as an enzyme that regulates glycogen synthesis in response to insulin (1). GSK-3 is a ubiquitously expressed serine/threonine protein kinase that phosphorylates and inactivates glycogen synthase. GSK-3 is a critical downstream element of the PI3K/Akt cell survival pathway whose activity can be inhibited by Akt-mediated phosphorylation at Ser21 of GSK-3α and Ser9 of GSK-3β (2,3). GSK-3 has been implicated in the regulation of cell fate in Dictyostelium and is a component of the Wnt signaling pathway required for Drosophila, Xenopus, and mammalian development (4). GSK-3 has been shown to regulate cyclin D1 proteolysis and subcellular localization (5).
- Welsh, G.I. et al. (1996) Trends Cell. Biol. 6, 274-279.
- Srivastava, A.K. and Pandey, S.K. (1998) Mol. Cell. Biochem. 182, 135-141.
- Cross, D.A. et al. (1995) Nature 378, 785-789.
- Nusse, R. (1997) Cell 89, 321-323.
- Diehl, J.A. et al. (1998) Genes Dev. 12, 3499-3511.
For Research Use Only. Not For Use In Diagnostic Procedures.